Literature DB >> 31419572

Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey.

Sarah Ballou1, Courtney McMahon2, Ha-Neul Lee2, Jesse Katon2, Andrea Shin3, Vikram Rangan2, Prashant Singh2, Judy Nee2, Michael Camilleri4, Anthony Lembo2, Johanna Iturrino2.   

Abstract

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) is associated with significant disease burden and decreased quality of life (QOL). We investigated the effects of IBS on different areas of daily function and compared these among disease subtypes.
METHODS: The Life with IBS survey was conducted by Gfk Public Affairs & Corporate Communications from September through October 2015. Respondents met Rome III criteria for constipation-predominant or diarrhea-predominant IBS (IBS-C and IBS-D, respectively). Data were collected from 3254 individuals (mean age, 47 years; 81% female; and 90% Caucasian) who met IBS criteria.
RESULTS: Respondents who were employed or in school (n = 1885) reported that IBS symptoms affected their productivity an average of 8.0 days out of the month and they missed approximately 1.5 days of work/school per month because of IBS. More than half the individuals reported that their symptoms were very bothersome. Individuals with IBS-C were more likely than with IBS-D to report avoiding sex, difficulty concentrating, and feeling self-conscious. Individuals with IBS-D reported more avoidance of places without bathrooms, difficulty making plans, avoiding leaving the house, and reluctance to travel. These differences remained when controlling for symptom bothersomeness, age, sex, and employment status. In exchange for 1 month of relief from IBS, more than half of the sample reported they would be willing to give up caffeine or alcohol, 40% would give up sex, 24.5% would give up cell phones, and 21.5% would give up the internet for 1 month.
CONCLUSIONS: Although the perceived effects of IBS symptoms on productivity are similar among its subtypes, patients with IBS-C and IBS-D report differences in specific areas of daily function.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abdominal Pain; Absenteeism; Daily Living; Presenteeism

Year:  2019        PMID: 31419572      PMCID: PMC7675784          DOI: 10.1016/j.cgh.2019.08.016

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  21 in total

1.  Severe sexual dysfunction in women with the irritable bowel syndrome: comparison with inflammatory bowel disease and duodenal ulceration.

Authors:  E Guthrie; F H Creed; P J Whorwell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

2.  Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.

Authors:  Prashant Singh; Kyle Staller; Kenneth Barshop; Elaine Dai; Jennifer Newman; Sonia Yoon; Shahar Castel; Braden Kuo
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 3.  A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.

Authors:  Dave Nellesen; Kimberly Yee; Anita Chawla; Barbara Edelman Lewis; Robyn T Carson
Journal:  J Manag Care Pharm       Date:  2013 Nov-Dec

4.  Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.

Authors:  Pierre Paré; James Gray; Sy Lam; Robert Balshaw; Shideh Khorasheh; Martin Barbeau; Suzanne Kelly; Christopher R McBurney
Journal:  Clin Ther       Date:  2006-10       Impact factor: 3.393

5.  Suicidal ideation in patients with irritable bowel syndrome.

Authors:  Vivien Miller; Louise Hopkins; Peter J Whorwell
Journal:  Clin Gastroenterol Hepatol       Date:  2004-12       Impact factor: 11.382

6.  The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

Authors:  A P S Hungin; P J Whorwell; J Tack; F Mearin
Journal:  Aliment Pharmacol Ther       Date:  2003-03-01       Impact factor: 8.171

7.  Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center.

Authors:  Prashant Singh; Abhishek Agnihotri; Manish K Pathak; Asef Shirazi; Rajeew P Tiwari; V Sreenivas; Rajesh Sagar; Govind K Makharia
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

8.  Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.

Authors:  Åsa Frändemark; Hans Törnblom; Sofie Jakobsson; Magnus Simrén
Journal:  Am J Gastroenterol       Date:  2018-09-25       Impact factor: 10.864

9.  Partner burden in irritable bowel syndrome.

Authors:  Reuben K Wong; Douglas A Drossman; Stephan R Weinland; Carolyn B Morris; Jane Leserman; Yuming Hu; Renuka Kelapure; Shrikant I Bangdiwala
Journal:  Clin Gastroenterol Hepatol       Date:  2012-07-31       Impact factor: 11.382

10.  More negative self-esteem and inferior coping strategies among patients diagnosed with IBS compared with patients without IBS--a case-control study in primary care.

Authors:  Ewa Grodzinsky; Susanna Walter; Lisa Viktorsson; Ann-Kristin Carlsson; Michael P Jones; Åshild Faresjö
Journal:  BMC Fam Pract       Date:  2015-01-28       Impact factor: 2.497

View more
  14 in total

Review 1.  Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.

Authors:  Xue Shang; Fen-Fen E; Kang-Le Guo; Yan-Fei Li; Hong-Lin Zhao; Yan Wang; Nan Chen; Tao Nian; Chao-Qun Yang; Ke-Hu Yang; Xiu-Xia Li
Journal:  Nutrients       Date:  2022-06-15       Impact factor: 6.706

2.  The relationships between IBS and perceptions of physical and mental health-a Norwegian twin study.

Authors:  Julia Kutschke; Jennifer R Harris; May-Bente Bengtson
Journal:  BMC Gastroenterol       Date:  2022-05-28       Impact factor: 2.847

Review 3.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

4.  Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome.

Authors:  Andrea Shin; Sarah Ballou; Michael Camilleri; Huiping Xu; Anthony Lembo
Journal:  Clin Gastroenterol Hepatol       Date:  2019-09-20       Impact factor: 11.382

5.  Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome.

Authors:  Gerardo Calderon; Chirag Patel; Michael Camilleri; Toyia James-Stevenson; Matthew Bohm; Robert Siwiec; Nicholas Rogers; John Wo; Carolyn Lockett; Anita Gupta; Huiping Xu; Andrea Shin
Journal:  J Clin Gastroenterol       Date:  2022-03-01       Impact factor: 3.062

Review 6.  Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options.

Authors:  Emily V Wechsler; Eric D Shah
Journal:  Drugs       Date:  2021-11-02       Impact factor: 9.546

Review 7.  Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review.

Authors:  Luis Alberto Bravo-Vázquez; Ixchel Medina-Ríos; Luis David Márquez-Gallardo; Josué Reyes-Muñoz; Francisco I Serrano-Cano; Surajit Pathak; Antara Banerjee; Anindya Bandyopadhyay; Asim K Duttaroy; Sujay Paul
Journal:  Dig Dis Sci       Date:  2022-05-04       Impact factor: 3.487

Review 8.  Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions.

Authors:  Sophie Fowler; Emily C Hoedt; Nicholas J Talley; Simon Keely; Grace L Burns
Journal:  Front Neurosci       Date:  2022-03-09       Impact factor: 4.677

9.  Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.

Authors:  William D Chey; Gregory S Sayuk; Wilmin Bartolini; David S Reasner; Susan M Fox; Wieslaw Bochenek; Ramesh Boinpally; Elizabeth Shea; Kenneth Tripp; Niels Borgstein
Journal:  Am J Gastroenterol       Date:  2021-02-01       Impact factor: 12.045

Review 10.  Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.

Authors:  Eric D Shah; Brian E Lacy; William D Chey; Lin Chang; Darren M Brenner
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.